What Legal Changes Are Occurring for Psilocybin in the U.S.?

Navigating the Evolving Legal Status of Psilocybin

​

The legal status of psilocybin, a psychedelic substance found in certain mushrooms, is undergoing significant changes in the United States, reflecting a shift in how psychedelic substances are perceived for medical and therapeutic use.

​

Current Federal Status

As of now, psilocybin remains classified as a Schedule I drug under the United States Controlled Substances Act, indicating a drug with no currently accepted medical use and a high potential for abuse. However, this classification is under review as new research highlights its potential therapeutic benefits.

State-Level Decriminalization and Legalization

​

Several cities and states are moving towards decriminalizing or even legalizing psilocybin, especially for medicinal and therapeutic purposes. For example:

• Denver, Colorado, became the first city to decriminalize psilocybin mushrooms in 2019.

• Oregon passed a measure in 2020 to legalize psilocybin therapy, which is now being implemented under a regulated framework.

• California and New York are considering bills that would decriminalize the use of psilocybin.​

​

Therapeutic Research Programs

The FDA has designated psilocybin therapy as a "breakthrough therapy" for depression, which accelerates the development and review process for drugs that show substantial improvement over existing treatments. This designation has spurred increased clinical trials and could lead to changes in federal classification if positive outcomes continue.

​

Future Outlook

The legal landscape for psilocybin is likely to continue evolving as more research supports its safety and efficacy in treating mental health disorders. Advocates for psychedelic medicine predict that, like cannabis, psilocybin will see wider decriminalization and potential legalization for medical use in the coming years.

​

Conclusion

Individuals interested in the use of psilocybin for therapeutic purposes should stay informed of local laws and regulations, as these can vary significantly by region. The growing support for psilocybin as a treatment option reflects a broader reevaluation of how psychedelic substances are understood and regulated in the U.S.